Sertraline treatment of hallucinogen persisting perception disorder.

Suppr

超能文献

作者信息

Young C R

出版信息

J Clin Psychiatry. 1997 Feb;58(2):85. doi: 10.4088/jcp.v58n0206a.

DOI:10.4088/jcp.v58n0206a

PMID:9062378

Abstract

摘要

相似文献

Sertraline treatment of hallucinogen persisting perception disorder.

J Clin Psychiatry. 1997 Feb;58(2):85. doi: 10.4088/jcp.v58n0206a.

Naltrexone treatment of hallucinogen persisting perception disorder.

Am J Psychiatry. 1997 Mar;154(3):437. doi: 10.1176/ajp.154.3.437a.

Sertraline and breast-feeding.

N Engl J Med. 1997 Apr 17;336(16):1189-90. doi: 10.1056/NEJM199704173361615.

Sertraline: a new antidepressant.

Am Fam Physician. 1993 Aug;48(2):311-4.

[Drug of the month. Sertraline (Serlain)].

Rev Med Liege. 1994 Sep 1;49(9):519-20.

Sertraline for premenstrual dysphoric disorder.

JAMA. 1998 Feb 4;279(5):357-8. doi: 10.1001/jama.279.5.357.

Sertraline in the treatment of neurotic excoriations and related disorders.

Arch Dermatol. 1996 May;132(5):589-90. doi: 10.1001/archderm.1996.03890290131022.

LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents.

J Pediatr. 1994 Nov;125(5 Pt 1):817-9. doi: 10.1016/s0022-3476(94)70083-4.

Clonidine treatment for hallucinogen persisting perception disorder.

Am J Psychiatry. 1998 Oct;155(10):1460. doi: 10.1176/ajp.155.10.1460.

The role of sertraline in the management of depression.

Clin Ther. 1994 Sep-Oct;16(5):768-82; discussion 767.

引用本文的文献

Pharmacological Treatment of Hallucinogen Persisting Perception Disorder (HPPD): A Systematic Review.

Harv Rev Psychiatry. 2025 Sep 1;33(5):264-275. doi: 10.1097/HRP.0000000000000439. Epub 2025 Sep 9.

Adverse psychiatric effects of psychedelic drugs: a systematic review of case reports.

Psychol Med. 2024 Nov 20;54(15):1-13. doi: 10.1017/S0033291724002496.

Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives.

Brain Sci. 2018 Mar 16;8(3):47. doi: 10.3390/brainsci8030047.

The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.

Front Psychiatry. 2017 Nov 20;8:240. doi: 10.3389/fpsyt.2017.00240. eCollection 2017.

Hallucinogen-persisting perception disorder.

Ther Adv Psychopharmacol. 2012 Oct;2(5):199-205. doi: 10.1177/2045125312451270.

Hallucinogen persisting perception disorder in neuronal networks with adaptation.

J Comput Neurosci. 2012 Feb;32(1):25-53. doi: 10.1007/s10827-011-0335-y. Epub 2011 Jun 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Sertraline treatment of hallucinogen persisting perception disorder.

J Clin Psychiatry. 1997 Feb;58(2):85. doi: 10.4088/jcp.v58n0206a.

Naltrexone treatment of hallucinogen persisting perception disorder.

Am J Psychiatry. 1997 Mar;154(3):437. doi: 10.1176/ajp.154.3.437a.

Sertraline and breast-feeding.

N Engl J Med. 1997 Apr 17;336(16):1189-90. doi: 10.1056/NEJM199704173361615.

Sertraline: a new antidepressant.

Am Fam Physician. 1993 Aug;48(2):311-4.

[Drug of the month. Sertraline (Serlain)].

Rev Med Liege. 1994 Sep 1;49(9):519-20.

Sertraline for premenstrual dysphoric disorder.

JAMA. 1998 Feb 4;279(5):357-8. doi: 10.1001/jama.279.5.357.

Sertraline in the treatment of neurotic excoriations and related disorders.

Arch Dermatol. 1996 May;132(5):589-90. doi: 10.1001/archderm.1996.03890290131022.

LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents.

J Pediatr. 1994 Nov;125(5 Pt 1):817-9. doi: 10.1016/s0022-3476(94)70083-4.

Clonidine treatment for hallucinogen persisting perception disorder.

Am J Psychiatry. 1998 Oct;155(10):1460. doi: 10.1176/ajp.155.10.1460.

The role of sertraline in the management of depression.

Clin Ther. 1994 Sep-Oct;16(5):768-82; discussion 767.

引用本文的文献

Pharmacological Treatment of Hallucinogen Persisting Perception Disorder (HPPD): A Systematic Review.

Harv Rev Psychiatry. 2025 Sep 1;33(5):264-275. doi: 10.1097/HRP.0000000000000439. Epub 2025 Sep 9.

Adverse psychiatric effects of psychedelic drugs: a systematic review of case reports.

Psychol Med. 2024 Nov 20;54(15):1-13. doi: 10.1017/S0033291724002496.

Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives.

Brain Sci. 2018 Mar 16;8(3):47. doi: 10.3390/brainsci8030047.

The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.

Front Psychiatry. 2017 Nov 20;8:240. doi: 10.3389/fpsyt.2017.00240. eCollection 2017.

Hallucinogen-persisting perception disorder.

Ther Adv Psychopharmacol. 2012 Oct;2(5):199-205. doi: 10.1177/2045125312451270.

Hallucinogen persisting perception disorder in neuronal networks with adaptation.

J Comput Neurosci. 2012 Feb;32(1):25-53. doi: 10.1007/s10827-011-0335-y. Epub 2011 Jun 14.